‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.

A NEW potential side effect of ‘Ozempic-style’ fat jabs has been discovered, putting experts on edge. The injections have ...

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

While Victoza sales are falling as patients switch to newer, once-weekly drugs like semaglutide-based Ozempic and Wegovy – used for diabetes and obesity – the once-daily product still made ...

Americans shelled out an estimated $71 billion for weight-loss drugs in 2023 - that is as much as the U.S. government disbursed in foreign aid the same year, according to ForeignAssistance.gov.

A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...

Victoza is Novo Nordisk’s once-daily injectable GLP-1 agonist and made around $3.6 billion in sales last year, making it the top-selling drug in the category.